ACC 2026: Meta analysis supports CagriSema as superior first line therapy in obesity Pharmaceutical Technology CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 Hypertension Understanding Cagrilintide: Benefits and Uses Cagrilintide is a novel, long acting peptide designed to target multiple receptors involved in appetite regulation and energy balance. Unlike traditional weight loss medications that often target a single pathway, cagrilintide acts as